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Background: The diagnosis of hereditary angioedema (HAE) is often delayed due to the low awareness of this
condition. In patients with undiagnosed HAE, abdominal symptoms often create the risk of unnecessary surgical
operation and/or drug therapy. To explore the cause of misdiagnosis, we compared the laboratory findings of HAE
patients under normal conditions with those during abdominal attacks.
Methods: Patient medical histories were analyzed and laboratory data at the first consultation with no symptoms
and no medication were compared with those at visits to the emergency department during severe attacks.
Results: Fourteen HAE patients were enrolled. Initial HAE symptoms occurred at 20.2 ± 9.4 years of age. The correct
diagnosis of HAE was made 22.7 ± 14.2 years after the initial symptoms. A common site of angioedema was the
extremities. Half of the patients experienced a life-threatening laryngeal attack and/or severe abdominal pain. In the
patients with severe abdominal pain, significant leukocytosis with neutrophilia along with increased levels of
hematocrit were observed while levels of C-reactive protein (CRP) remained low. All severe attacks were alleviated
with an infusion of C1-inhibitor concentrate.
Conclusions: Consideration of the likelihood of a HAE attack is important when patients present with acute
abdominal pain and leukocytosis without elevation of CRP.
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Hereditary angioedema (HAE) is an autosomal dominant
disease, caused by an inherited deficiency of functionally
active C1 inhibitor (C1-INH). Episodic local angioedema
is due to the release of bradykinin from high molecular
weight kininogen via activation of the contact system
which increases vascular permeability during HAE attacks
[1]. Clinically, HAE is characterized by the presence of
subcutaneous or submucosal tissue swelling, usually affec-
ting the face, extremities, upper airways and/or gastro-
intestinal tract (GI-tract) [2].
While HAE is known to be inherited in an autosomal
dominant form, 20-30% of cases develop as a result of
de novo mutation [3]. The prevalence of this disease has* Correspondence: yasu@juntendo.ac.jp
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reproduction in any medium, provided the orbeen estimated at 1 case per 50,000 people, with no
reported bias in different ethnic groups [1,3,4]. Plasma-
derived C1-INH concentrate has been the first-line treat-
ment for acute HAE attacks for decades, however, new
drugs, such as a bradykinin B2 receptor antagonist and a
kallikrein inhibitor are available in some countries [2].
Despite the availability of treatments for HAE, the global
disease recognition rate is low. We previously conducted
a recognition survey of HAE among Japanese physicians:
55% of all responding physicians (n = 4,495) failed to
recognize HAE and 11% overlooked or misdiagnosed
their patients [5]. Recently, we established a HAE Infor-
mation Center on the Internet [6] (in Japanese), which
aims to promote the recognition of HAE.
When severe edema develops in the airways, a patient’s
condition may become life-threatening. When the GI-
tract is involved in a HAE attack, edema of the gastro-
intestinal walls causes abdominal pain, nausea, vomitingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that of an acute abdomen and is difficult to distinguish
from a surgical emergency [7]. To date, no detailed obser-
vations are available which describe the laboratory data in
HAE patients having abdominal attacks. In this study,
HAE patients were followed and the laboratory findings of
patients with no symptoms versus those with critical
abdominal attacks were retrospectively compared.
Methods
At the outpatient clinic of Juntendo University Hospital,
Tokyo, Japan, HAE patients were followed from January
2011 to August 2012. They were diagnosed based on
their clinical histories and laboratory data (antigenic
levels of C4 and functional levels of C1-INH). As the
evaluation of the antigenic level of C1-INH is not
approved by the Japanese health insurance system, the
HAE diagnosis criteria described by Agostoni et al. [8]
was used for these patients. The study was conducted in
accordance with the Declaration of Helsinki (1964) and
was approved by the Institutional Review Board at
Juntendo University. Written informed consent was
obtained from all participating patients.
Family and past medical histories were collected from
patients’ medical records. Blood samples were obtained
after each patient’s first consultation for differential diag-
nosis of angioedema under normal conditions (no swell-
ing or medication). All blood samples were obtained
from the antecubital vein and biochemical analyses,
including white blood cells (WBC), hemoglobin, hema-
tocrit (Hct), serum creatinine, total protein, albumin,
immunoglobulin (Ig) G, IgA, IgM, C3, C4, total hemolytic
complement (CH50), C-reactive protein (CRP), anti-
nuclear antibody (ANA), and immune complex (C1q-
binding assay) were performed. Functional levels of C1-
INH were determined using a chromogenic assay
(Sysmex, Hyogo, Japan). Blood was donated by 10 of 14
patients for determining the antigenic level of C1-INH
which was evaluated using nepherometry with antisera to
C1-INH (Dade Behring, Inc., Illinois, America). When
patients presented at the emergency department with a
severe attack, the following laboratory data were re-
evaluated: blood counts, WBC, C3, C4, CH50 and CRP in
sera. Abdominal computed tomography (A-CT) and ultra-
sonography were performed as needed. Based on the phy-
sicians’ decision, 20 U/kg bodyweight (bw) C1-INH
concentrate (Berinert® P, CSL Behring K.K.) was adminis-
tered intravenously. No patients received prophylactic
treatment with drugs such as androgens, kallikrein inhibi-
tor and bradykinin B2 receptor antagonist throughout
their clinical passage.
The GraphPad Prism 5J software for Windows (version
5.04; GraphPad, San Diego, CA, USA) was used for statis-
tical analysis, and the two-sided p-value < 0.05 was takenas the level for statistical significance. All data were
expressed as mean ± standard deviation (SD).
Results
Fourteen patients with HAE (5 men and 9 women) visited
our outpatient clinic. The mean (±SD) age was 44.1 ± 14.4
years. Initial HAE symptoms occurred at 20.2 ± 9.4 years
of age, with a delay in correct diagnosis of HAE of 22.7 ±
14.2 years after the initial symptoms. A family history of
angioedema was noted in 12 of the 14 patients (86%). All
of the patients had experienced self-limiting, noninflam-
matory subcutaneous angioedema without major urticarial
rash, often recurrent and often lasting for more than 12
hours. Trauma, dental procedure and stress could have
been the triggering episode, but many attacks occurred
without an identifiable stimulus. The frequencies of
episodic swelling varied between patients. Swelling of
extremities was a common symptom but the affected
organs varied by patient. Almost all attacks spontaneously
resolved within one hour to three days, however, six pa-
tients (No. 1, 6, 7, 8, 9, and 12) experienced a recurrent
life-threatening laryngeal attack and/or severe abdominal
pain. These severe symptoms had been misinterpreted as
allergies, asthma, appendicitis, GI-tract perforation, GI-
tract bleeding and/or enterocolitis. Two patients (No. 1
and 6) had previously undergone tracheotomy because of
airway obstruction. Three patients had received abdo-
minal surgery due to appendicitis, an ovarian cyst and
myoma.
Table 1 shows laboratory data of results obtained on
the first visit to our outpatient clinic (when there were
no symptoms). Serum levels of C3 were within or above
the normal range (69-128 mg/dL) in all but one patient
(No. 14) while levels of C4 were below the normal range
(14-36 mg/dL) in all cases. Functional levels of C1-INH
were also below the normal range (70-130%) in all pa-
tients. Therefore, all patients fulfilled the criteria for the
diagnosis of HAE [8]. One patient (No.11) had a weakly
positive ANA titer (1:80) while all others were negative.
Four patients (No. 2, 4, 9, and 10) gave positive results
for immune complex, but their first symptoms of
angioedema had occurred before the age of 15 years and
they had no clinical symptoms of autoimmune diseases.
A total of 31 visits to the emergency department were
recorded (Table 2). Of these, 28 were due to severe
attacks and the patients were treated with C1-INH
concentrate (20 U/kg bw). C1-INH concentrate therapy
was effective in alleviating symptoms and all patients
returned home without hospital admission. Relatively
mild attacks (foot and lips) either received no medica-
tion or were treated with tranexamic acid.
Severe colicky abdominal pain was observed a total of
17 times in six of 14 patients. Figure 1(a-d) shows rep-
resentative A-CT images of a patient (aged 33 years,












(mg/dL)Function (%) Antigen (mg/dl)
Normal range 69-128 14-36 25-54 70-130 11-26 3600-8900 380-504 35.6-45.4 <0.2
1 159 3 24.2 35 n.t. 7100 512 42.2 2.1
2 103 <2 9.7 <25 7 5100 414 39.1 0.3
3 100 9 39 30 <6 4100 487 43.8 0.2
4 140 5 33.4 29 10 4900 430 39.2 0.7
5 93 3 22.9 <25 n.t. 5900 475 43.6 0.1
6 106 7 33 29 8 7800 454 40.7 0.2
7 105 3 27 <25 <6 7700 490 44.7 0.4
8 n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t.
9 97 4 25.8 <25 7 6100 462 39.9 0.2
10 97 5 25.1 <25 <6 8400 470 43.2 0.1
11 112 10 51.5 39 14 9700 432 41.6 0.1
12 124 8 46 <25 n.t. 7000 526 47.1 0.1
13 95 9 33 33 10 3800 470 43.2 0.0
14 67 10 32.3 34 15 5600 365 36.1 0.0
C1-INH C1 inhibitor, CH50 total hemolytic complement; CRP C-reactive protein, Hct hematocrit, n.t. not tested, RBC red blood cell, WBC white blood cell.
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ascites. The stomach was distended due to a GI-tract
obstruction.
The number of WBCs at the time of severe abdominal
attack was higher (12,253 ± 3,148 /μL) than those under
normal conditions (6,400 ± 1,740 /μL) [p < 0.01] and
during attacks involving other sites (6,942 ± 1,393 /μL)Table 2 Total frequencies of emergency department
visits, affected organs and treatment










Face + Neck + Hand 1
Shoulder + Larynx 1
Tranexamic acid 1
Foot 1
Observation (No medication) 2
Lips 1
Foot 1
GI-tract gastrointestinal tract.[p < 0.01]. However, the levels of CRP were low during
normal conditions, abdominal attacks and attacks at
other sites (Figure 2). The number of red blood cells at
the time of severe abdominal attack (527 ± 50 ×104/μL)
was higher than that under normal conditions (459 ±
42×104/μL) [p < 0.01]. The level of Hct at the time of
severe abdominal attack (46.1 ± 3.0%) was higher than
that under normal conditions (41.7 ± 2.8%) [p < 0.01].
The percentage of neutrophils was higher at the time of
severe abdominal attack compared with that under
normal conditions (84.1 ± 6.9% versus 61.2 ± 13.2%, res-
pectively; [p < 0.01]) [Figure 3].
Discussion
While the actual diagnosis of HAE is commonly made
in the second or third decade of life, symptoms often
begin earlier. As the symptoms of HAE mimic other
disorders they are often misinterpreted [8]. An inter-
national consensus algorithm for the diagnosis of HAE
[9] and a Japanese guideline of HAE [10] have been pub-
lished and describe the determination of antigenic levels
of C1-INH as needed for the classification of HAE into
type I or type II. However, Japanese health insurance
limitations have created a problem in this evaluation. In
our study, taking a detailed history of the recurrent
angioedema as well as a family history was helpful for
suspecting HAE. The detection of low levels of C4 is the
key test for screening HAE patients. Our examination
confirmed the diagnosis of HAE in 100% of patients by
measuring functional levels of C1-INH and serum levels







Figure 1 Enhanced abdominal computed tomography (A-CT) of severe gastrointestinal edema. a: Liver-stomach level slice, b: Kidney level
slice, c: Under umbilical level slice, d: Pelvis level slice. Patient No. 3 visited the emergency department because of severe abdominal pain and
vomiting. Obstructive duodenum (arrow) of the small intestine (arrow head) was visualized due to the thickening of the gastrointestinal walls.
Gastric (*) and intestinal walls (‡) were expanded. Moderate ascites was observed around liver (†). (Photos were provided by Dr. N. Hosoi,
Tokyo-Kita social insurance hospital).
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enrolled in this study, the gender ratio and number of
patients with a family history of angioedema were com-
parable with previous reports [1,3,9].
Frank et al. reported that abdominal pain, nausea and
vomiting are the dominant symptoms of HAE in approxi-



















Figure 2 Measurement of white blood cells (WBC), hematocrit (Hct) awithin five days [13]. Furthermore, approximately one-
third of patients with abdominal attacks undergo unneces-
sary surgery, such as appendectomy and exploratory
laparotomy [14]. Since these abdominal symptoms are
relatively nonspecific, the response to treatment with C1-
INH concentrate may be the only way to differentiate a




















Figure 3 Percentage of neutrophils in the white blood cells
(WBC) of the peripheral blood.
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ment 31 times: 28 of the 31 attacks were severe and
treated with C1-INH concentrate which is the only
licensed HAE therapy in Japan. After treatment, all
symptoms resolved without any side effects and all
patients were able to return home.
To date, there has only been one case report describ-
ing the occurrence of leukocytosis during an abdominal
HAE attack [16]. In our study, the number of WBCs in
patients with abdominal attacks was significantly higher
than those under normal conditions and during attacks
at other sites, while serum levels of CRP showed no sig-
nificant difference. Although no statistical correlation
was observed between attack duration and the number
of WBCs, in all cases where an attack had started over 8
hours before the emergency department visit, the num-
ber of WBCs was over 12,000 μL. In the context of a
usual bacterial infection, leukocytosis is recognized prior
to an increase of CRP. Such a situation mimics the
super-acute state of a GI-tract infection (e.g., appendi-
citis) and/or gastrointestinal perforation; however, our
patients’ symptoms were alleviated without antibiotics.
The main population of WBCs showed increased
neutrophils without an increase of CRP. We have not
addressed the mechanisim of alteration of the WBC
population, although it is possible to envisage a scenario
in which these findings demonstrate an unexpected rolefor the sympathetic nervous system. The number of
neutrophils is known to be altered in the response to
non-pathologic situations such as emotional or physical
stressors [17]. These mechanisms are explained by the
β-adrenergic effect of epinephrine, which diminishes
neutrophil adherence to the endothelial cells [18,19].
When HAE patients presented with severe abdominal
pain, we also found a significant increase in Hct. Simul-
taneously, the levels of total protein and albumin in sera
tended to increase during abdominal attacks (data not
shown) but lacked significance. Since red blood cells
cannot pass through capillary walls, we could obtain a
statistically significant difference. Our previous report
also presented a case of severe angioedema which had
spread to the patient’s whole body, contributing to a
weight gain of nearly 20 kg [20]. It appears that dehydra-
tion and the fluctuation of Hct reflects massive fluid
translocation from the blood stream to the GI-tract wall.
If angioedema could not be alleviated, these severe cases
would register hypovolemic shock from extravascular
fluid loss [21] and mimic GI-tract bleeding or vagotonic
shock due to intolerable pain.
Conclusions
During abdominal attacks in patients with HAE, leuko-
cytosis and high Hct without CRP elevation can be
confused with an acute abdomen needing an emergency
surgical procedure. Thus, consideration of the likelihood
of a HAE attack is of clinical importance in such cases.
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